145 related articles for article (PubMed ID: 3455829)
1. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia.
Daenen S; Vellenga E; van Dobbenburgh OA; Halie MR
Blood; 1986 Feb; 67(2):559-61. PubMed ID: 3455829
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations.
Flynn PJ; Miller WJ; Weisdorf DJ; Arthur DC; Brunning R; Branda RF
Blood; 1983 Dec; 62(6):1211-7. PubMed ID: 6580050
[TBL] [Abstract][Full Text] [Related]
3. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia.
Nilsson B
Br J Haematol; 1984 Jul; 57(3):365-71. PubMed ID: 6589010
[TBL] [Abstract][Full Text] [Related]
4. The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia.
Fontana JA; Rogers JS; Durham JP
Cancer; 1986 Jan; 57(2):209-17. PubMed ID: 3455835
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acid.
Griggs JJ; Henley SE; Rowe JM
Am J Hematol; 1994 Feb; 45(2):177-80. PubMed ID: 8141124
[TBL] [Abstract][Full Text] [Related]
6. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhoa L; Gu LJ; Wang ZY
Blood; 1988 Aug; 72(2):567-72. PubMed ID: 3165295
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
[TBL] [Abstract][Full Text] [Related]
8. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.
Miller WH; Jakubowski A; Tong WP; Miller VA; Rigas JR; Benedetti F; Gill GM; Truglia JA; Ulm E; Shirley M
Blood; 1995 Jun; 85(11):3021-7. PubMed ID: 7756637
[TBL] [Abstract][Full Text] [Related]
9. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract][Full Text] [Related]
10. Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Dulaney AM; Murgatroyd RJ
Ann Pharmacother; 1993 Feb; 27(2):211-4. PubMed ID: 8439701
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid and in vitro cytokine production by acute promyelocytic leukemia cells.
Visani G; Tosi P; Ottaviani E; Zaccaria A; Baccini C; Manfroi S; Pastano R; Remiddi C; Morelli A; Molinari AL; Zanchini R; Tura S
Eur J Haematol; 1996 Oct; 57(4):301-6. PubMed ID: 8982293
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
Limentani SA; Pretell JO; Potter D; DuBois JS; Daoust PR; Spieler PS; Miller KB
Am J Hematol; 1994 Sep; 47(1):50-5. PubMed ID: 8042616
[TBL] [Abstract][Full Text] [Related]
13. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients.
Chen ZX; Xue YQ; Zhang R; Tao RF; Xia XM; Li C; Wang W; Zu WY; Yao XZ; Ling BJ
Blood; 1991 Sep; 78(6):1413-9. PubMed ID: 1884013
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
Dreosti LM; Bezwoda W; Gunter K
Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655
[TBL] [Abstract][Full Text] [Related]
15. Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia.
Tallman MS
Leukemia; 1996 Apr; 10 Suppl 1():S12-5. PubMed ID: 8618462
[TBL] [Abstract][Full Text] [Related]
16. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
17. Probing the pathobiology of response to all-trans retinoic acid in acute promyelocytic leukemia: premature chromosome condensation/fluorescence in situ hybridization analysis.
Vyas RC; Frankel SR; Agbor P; Miller WH; Warrell RP; Hittelman WN
Blood; 1996 Jan; 87(1):218-26. PubMed ID: 8547645
[TBL] [Abstract][Full Text] [Related]
18. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
[TBL] [Abstract][Full Text] [Related]
19. Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia.
Soignet SL; Benedetti F; Fleischauer A; Parker BA; Truglia JA; Ra Crisp M; Warrell RP
Leukemia; 1998 Oct; 12(10):1518-21. PubMed ID: 9766493
[TBL] [Abstract][Full Text] [Related]
20. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
